Clinical Trial Update: Patient Preferences for Precision Medicine: Determining Optimal Patient Quality of Life Using PARPi's [NA]

View source ↗

Summary

A University of Saskatchewan study is investigating patient preferences and quality of life in precision medicine for ovarian cancer using PARP inhibitors. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: University of Saskatchewan | Conditions: Ovarian Cancer, Quality of Life | NA | Status: RECRUITING